Analyst Consensus
- Current Price
- 142.41 $
- Target (Low)
- 115.00 $
- Target (Mean)
- 156.47 $
- Target (High)
- 181.00 $
- Recommendation
- Buy
- Number of Analysts
- 37
Recommendation Distribution
Recommendation Distribution| Strong Buy | 4 |
|---|
| Buy | 19 |
|---|
| Hold | 18 |
|---|
| Sell | 2 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 19.9%
- Operating Margin
- 3.2%
- Gross Margin
- 82.9%
- Return on Equity (ROE)
- 32.3%
- Return on Assets (ROA)
- 6.2%
- Revenue Growth
- 17.9%
- Earnings Growth
- 6.0%
- Debt/Equity
- 33.19
- Current Ratio
- 1.44
- Beta
- 1.16
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 12, 2026 | Truist Securities | Hold → Hold |
| Jun 12, 2026 | Truist Securities | Hold → Hold |
| Jun 5, 2026 | CICC | Outperform |
| May 21, 2026 | RBC Capital | Outperform → Outperform |
| May 11, 2026 | DA Davidson | Buy → Buy |
| May 11, 2026 | Barclays | Equal-Weight → Equal-Weight |